Blood News and Research

RSS

Legislation grants improve research and employment initiatives in Indiana University medical campus

Indiana University School of Medicine scientists have received more than $12 million in grants funded by the federal economic stimulus legislation, funding that has bolstered both research initiatives and research employment on the medical center campus.

16 Sep 2009

RXi Pharmaceuticals to present in vivo data of rxRNA compounds

RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that it will be presenting new in vivo data on its self-delivering rxRNA compounds at a number of upcoming scientific conferences, detailed below.

16 Sep 2009

Genetically removing the osteopontin protein prevents lung diseases

In a development that could lead to a novel approach to the treatment of a devastating lung disease, biochemists at The University of Texas Health Science Center at Houston report they are the first to link the osteopontin (OPN) protein to chronic obstructive pulmonary disease (COPD).

16 Sep 2009

Research study investigates survival rates of prostate cancer patients across time periods

New research to be published in tomorrow's issue of the Journal of the American Medical Association (JAMA) (Vol. 302, No. 11), by a team at The Cancer Institute of New Jersey (CINJ), shows that men diagnosed with prostate cancer beginning in the early 1990's had significantly improved survival outcomes compared with patients whose cancers were diagnosed in prior decades.

16 Sep 2009

Stem cells - the answer to autoimmune diseases and cancer in the future

Stem cells are multipotent cells of the immune system. Scientists hope to use them for curing autoimmune diseases, cancer and innate genetic defects in the future.

16 Sep 2009

SSO2 administration reduces heart muscle damage

Supersaturated oxygen (SSO2) administered during catheter-based treatments for heart attack can significantly reduce heart muscle damage, according to a new study reported in Circulation: Cardiovascular Interventions, a journal of the American Heart Association.

16 Sep 2009

New cancer therapy involves remodelling blood vessels and activating immune cells

Reversing or re-arranging the growth of these vessels in combination with specific immune strategies is a promising new strategy for cancer therapy, says Ruth Ganss, Professor at the Western Australian Institute for Medical Research, Perth, at the 2nd European Congress of Immunology ECI 2009 held in Berlin.

16 Sep 2009

Cancer Program established to treat young cancer patients

A new partnership of Providence Health & Services, Childrens Hospital Los Angeles and the Childrens Hospital Los Angeles Medical Group has been developed to treat young adults with cancer, providing diagnostics and treatment for a group that nationwide falls in a gap between adult and pediatric health care.

16 Sep 2009

Breast cancer prevention drugs may negatively affect patients

Three drugs, including tamoxifen, reduce a woman's chance of getting breast cancer, but each drug carries distinct potential harms of its own, according to a new report from HHS' Agency for Healthcare Research and Quality.

16 Sep 2009

Damaged heart tissue is significantly reduced with supersaturated oxygen

Results of a clinical trial published today in Circulation: Cardiovascular Interventions demonstrate that an infusion of blood that is "supersaturated" with oxygen (SS02) can reduce the amount of damaged heart muscle immediately following a life-threatening heart attack

16 Sep 2009

Laser technology lowers manufacturing cost of artificial joints and arterial stents

Researchers are developing technologies that use lasers to create arterial stents and longer-lasting medical implants that could be manufactured 10 times faster and also less expensively than is now possible.

16 Sep 2009

Study reveals ineffectiveness of insulin and metformin against inflammatory biomarkers

In patients with recent onset type-2 diabetes, treatment with insulin or the diabetes drug metformin did not reduce inflammatory biomarkers, such as high-sensitivity C-reactive protein, although the treatment did improve glucose control, according to a study in the September 16 issue of JAMA.

16 Sep 2009

Study shows 29 percent patients experienced angina chest pain once a week

The world's largest quality of life study of chronic angina patients has revealed that almost one in three experience frequent chest pain, which affects their daily life.

16 Sep 2009

Comprehensive CT scan gives better indication of significant coronary artery disease

A team of researchers led by Massachusetts General Hospital (MGH) radiologists has developed a computed-tomography-based protocol that identifies both narrowing of coronary arteries and areas of myocardial ischemia - restricted blood flow to heart muscle tissue - giving a better indication of clinically significant coronary artery disease.

16 Sep 2009

Palatin Technologies to announce clinical trial results of PL-3994

Palatin Technologies, Inc. (NYSE Amex: PTN) announced that a poster on clinical trial results with PL-3994, its product for heart failure, will be presented today at the 13th Annual Scientific Meeting of the Heart Failure Society of America in Boston.

15 Sep 2009

Mantra medicine tool helps patients in healing process

Dr. Mitchell Earl Gibson, a board-certified medical doctor in High Point, North Carolina, has formed a company that creates mantra and prayer-meditation-based recordings.

15 Sep 2009

Lexicon initiates Phase 2 clinical trial of LX4211 in patients with type 2 diabetes mellitus

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, obtained favorable results from recently completed Phase 1 studies of LX4211 and announced today that it has initiated a Phase 2 clinical trial of the drug candidate in patients with type 2 diabetes mellitus.

15 Sep 2009

"High Five" factors in overweight men impacts their energy and health: Building Healthier America

For overweight men ages 45 and older, the "High Five" factors of high cholesterol, high blood pressure, high blood sugar/glucose, poor diet and low testosterone may be impacting their energy and health, sabotaging efforts to lose weight, according to Building Healthier America, a national nonprofit organization dedicated to reversing the negative trends of overweight and obesity in the U.S.

15 Sep 2009

Critical event experienced by 1 in 20 acutely-ill patients during air-medical transport

During air-medical transport of acutely-ill patients, 1 in 20 experience a critical event such as death, major resuscitation or blood pressure deterioration according to a new study http://www.cmaj.ca/press/cmaj080886.pdf in CMAJ (Canadian Medical Association Journal) www.cmaj.ca.

15 Sep 2009

Reliant Renal Care chooses Medisystems as supplier of Streamline airless blood tubing sets

NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that its wholly-owned subsidiary, Medisystems Corporation, has signed a new three-year product supply agreement with Reliant Renal Care, Inc., for the delivery of Streamline airless blood tubing sets, as well as MasterGuard(R) safety needles with FingerShield(R) to Reliant's dialysis center network.

15 Sep 2009

Blood News and Research

Legislation grants improve research and employment initiatives in Indiana University medical campus

RXi Pharmaceuticals to present in vivo data of rxRNA compounds

Genetically removing the osteopontin protein prevents lung diseases

Research study investigates survival rates of prostate cancer patients across time periods

Stem cells - the answer to autoimmune diseases and cancer in the future

SSO2 administration reduces heart muscle damage

New cancer therapy involves remodelling blood vessels and activating immune cells

Cancer Program established to treat young cancer patients

Breast cancer prevention drugs may negatively affect patients

Damaged heart tissue is significantly reduced with supersaturated oxygen

Laser technology lowers manufacturing cost of artificial joints and arterial stents

Study reveals ineffectiveness of insulin and metformin against inflammatory biomarkers

Study shows 29 percent patients experienced angina chest pain once a week

Comprehensive CT scan gives better indication of significant coronary artery disease

Palatin Technologies to announce clinical trial results of PL-3994

Mantra medicine tool helps patients in healing process

Lexicon initiates Phase 2 clinical trial of LX4211 in patients with type 2 diabetes mellitus

"High Five" factors in overweight men impacts their energy and health: Building Healthier America

Critical event experienced by 1 in 20 acutely-ill patients during air-medical transport

Reliant Renal Care chooses Medisystems as supplier of Streamline airless blood tubing sets

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News